What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Prostate cancer, Prostate, Prostatectomy, Internal medicine and Prostate-specific antigen are his primary areas of study.
His Prostate cancer study combines topics from a wide range of disciplines, such as Cancer research, Gynecology, Surgery and Urology.
The study incorporates disciplines such as Immunohistochemistry, Pathology, Gene expression, Stage and Adenocarcinoma in addition to Prostate.
His Prostatectomy research integrates issues from Prostate neoplasm, Biopsy, Salvage therapy, Erectile dysfunction and Prospective cohort study.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology and Oncology.
His Prostate-specific antigen research includes elements of Biochemical recurrence, Radiation therapy, Proportional hazards model and Retrospective cohort study.
His most cited work include:
- Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update (972 citations)
- Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes (542 citations)
- Surrogate End Point for Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation Therapy (448 citations)
What are the main themes of his work throughout his whole career to date?
Judd W. Moul spends much of his time researching Prostate cancer, Internal medicine, Prostatectomy, Prostate and Oncology.
Prostate-specific antigen is the focus of his Prostate cancer research.
His Prostate-specific antigen research is multidisciplinary, incorporating elements of Salvage therapy, Proportional hazards model and Retrospective cohort study.
His work on Internal medicine is being expanded to include thematically relevant topics such as Endocrinology.
In his study, Hazard ratio is inextricably linked to Urology, which falls within the broad field of Prostatectomy.
His Prostate study incorporates themes from Cancer research, Carcinoma, Cohort, Pathology and Adenocarcinoma.
He most often published in these fields:
- Prostate cancer (77.72%)
- Internal medicine (46.33%)
- Prostatectomy (42.03%)
What were the highlights of his more recent work (between 2011-2021)?
- Prostate cancer (77.72%)
- Internal medicine (46.33%)
- Oncology (31.77%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Prostate cancer, Internal medicine, Oncology, Prostatectomy and Urology.
Judd W. Moul has researched Prostate cancer in several fields, including Biopsy, Prostate and Gynecology.
Judd W. Moul interconnects Endocrinology and MEDLINE in the investigation of issues within Internal medicine.
His research integrates issues of Stage, Orchiectomy, Disease and Genitourinary Cancers in his study of Oncology.
He combines subjects such as Proportional hazards model, Radiation therapy, Surgery and Cohort with his study of Prostatectomy.
Judd W. Moul has included themes like Clinical endpoint and Hazard ratio in his Urology study.
Between 2011 and 2021, his most popular works were:
- Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer (283 citations)
- A Critical Analysis of the Long-Term Impact of Radical Prostatectomy on Cancer Control and Function Outcomes (161 citations)
- Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer (152 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Judd W. Moul focuses on Prostate cancer, Internal medicine, Oncology, Prostate and Urology.
The various areas that he examines in his Prostate cancer study include Gynecology and Surgery.
As part of his studies on Internal medicine, he often connects relevant subjects like Endocrinology.
His study in Oncology is interdisciplinary in nature, drawing from both Androgen deprivation therapy, Androgen, Disease, Biochemical recurrence and Orchiectomy.
His research in Prostate intersects with topics in Stage, Newly diagnosed, Biopsy and Radiation therapy.
His work in Urology addresses subjects such as Prostatectomy, which are connected to disciplines such as Erectile dysfunction, Sexual function and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
